Evidence-based guides on GLP-1 medicines and weight management
A complete comparison of whey and plant protein supplements for Indian GLP-1 users — covering leucine content, DIAAS scores, brands available in India, GI tolerance on semaglutide and tirzepatide, and how to choose the right protein supplement.
Read more→A complete comparison of oral Rybelsus and injectable Ozempic for Indian patients — covering bioavailability, trial data, weight loss outcomes, cost in India, storage challenges, and who should choose which form.
Read more→Millions of Indians live alone — students, migrants, divorced individuals — yet GLP-1 health advice assumes family support. This guide covers solo injection safety, emergency planning, meal prep for one, medication storage, and building a support network.
Read more→A week-by-week guide to the first month on GLP-1 medications in India — what to eat, how to manage nausea and constipation, when to call your doctor, and common mistakes to avoid.
Read more→How semaglutide and tirzepatide reverse non-alcoholic fatty liver disease — the clinical trial evidence, Indian-specific risk factors, and dietary guidance for NAFLD management on GLP-1 medications.
Read more→How semaglutide and tirzepatide reshape the gut microbiome — boosting Akkermansia muciniphila, butyrate production, and metabolic health — plus an Indian food guide to support this transformation.
Read more→GLP-1 medications require cold storage at 2–8°C — vulnerable to India's power cuts, monsoon floods, and summer heat. A practical guide to protecting Ozempic and Mounjaro through any emergency.
Read more→Most GLP-1 users hit a weight loss plateau between months 3 and 9. This guide explains why it happens physiologically and gives you eight concrete strategies tailored for Indian patients to restart progress.
Read more→A complete guide for fibromyalgia patients in India considering GLP-1 medications — how Ozempic and Mounjaro may reduce chronic pain and fatigue, overlapping symptoms to watch for, and step-by-step advice.
Read more→